Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Non-genetic diversity modulates population performance.

Waite AJ, Frankel NW, Dufour YS, Johnston JF, Long J, Emonet T.

Mol Syst Biol. 2018 Jan 10;14(1):e8149. doi: 10.15252/msb.20178149. No abstract available.

2.

Multiplexed fluctuation-dissipation-theorem calibration of optical tweezers inside living cells.

Yan H, Johnston JF, Cahn SB, King MC, Mochrie SGJ.

Rev Sci Instrum. 2017 Nov;88(11):113112. doi: 10.1063/1.5012782.

PMID:
29195389
3.

Non-genetic diversity modulates population performance.

Waite AJ, Frankel NW, Dufour YS, Johnston JF, Long J, Emonet T.

Mol Syst Biol. 2016 Dec 19;12(12):895. doi: 10.15252/msb.20167044. Erratum in: Mol Syst Biol. 2018 Jan 10;14 (1):e8149.

4.

Lateral meniscal cyst causing common peroneal palsy.

Jowett AJ, Johnston JF, Gaillard F, Anderson SE.

Skeletal Radiol. 2008 Apr;37(4):351-5. doi: 10.1007/s00256-007-0430-3. Epub 2008 Jan 12.

PMID:
18193217
5.

In vitro and in vivo effects of an alpha3 neuronal nicotinic acetylcholine receptor antisense oligonucleotide.

Adams MR, Nikkel AL, Donnelly-Roberts DL, Watt AT, Johnston JF, Cowsert LM, Butler M, Kroeger PE, Frost L, Curzon P, Decker MW, Bitner RS.

Brain Res Mol Brain Res. 2004 Oct 22;129(1-2):67-79.

PMID:
15469883
6.

A measure of effect size for experimental designs with heterogeneous variances.

Johnston JF, Berry KJ, Mielke PW Jr.

Percept Mot Skills. 2004 Feb;98(1):3-18.

PMID:
15058860
7.

2'-O-[2-[(N,N-dimethylamino)oxy]ethyl]-modified oligonucleotides inhibit expression of mRNA in vitro and in vivo.

Prakash TP, Johnston JF, Graham MJ, Condon TP, Manoharan M.

Nucleic Acids Res. 2004 Feb 3;32(2):828-33. Print 2004.

8.

Analgesic profile of intrathecal P2X(3) antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats.

Honore P, Kage K, Mikusa J, Watt AT, Johnston JF, Wyatt JR, Faltynek CR, Jarvis MF, Lynch K.

Pain. 2002 Sep;99(1-2):11-9.

PMID:
12237180
9.

A Phase I trial of H-ras antisense oligonucleotide ISIS 2503 administered as a continuous intravenous infusion in patients with advanced carcinoma.

Cunningham CC, Holmlund JT, Geary RS, Kwoh TJ, Dorr A, Johnston JF, Monia B, Nemunaitis J.

Cancer. 2001 Sep 1;92(5):1265-71.

PMID:
11571742
10.

Antisense properties of 2'-O-dimethylaminooxyethyl (2'-O-DMAOE) oligonucleotides.

Prakash TP, Kawasaki AM, Johnston JF, Graham MJ, Condon TP, Manoharan M.

Nucleosides Nucleotides Nucleic Acids. 2001 Apr-Jul;20(4-7):829-32.

PMID:
11563125
11.

Detection of progesterone receptor forms A and B by immunohistochemical analysis.

Mote PA, Johnston JF, Manninen T, Tuohimaa P, Clarke CL.

J Clin Pathol. 2001 Aug;54(8):624-30.

12.

Phase I Trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer.

Rudin CM, Holmlund J, Fleming GF, Mani S, Stadler WM, Schumm P, Monia BP, Johnston JF, Geary R, Yu RZ, Kwoh TJ, Dorr FA, Ratain MJ.

Clin Cancer Res. 2001 May;7(5):1214-20.

13.

Inhibition of C-raf expression by antisense oligonucleotides extends heart allograft survival in rats.

Stepkowski SM, Qu X, Wang ME, Tian L, Chen W, Wancewicz EV, Johnston JF, Bennett CF, Monia BP.

Transplantation. 2000 Aug 27;70(4):656-61.

PMID:
10972225
14.

Biophysical and antisense properties of oligodeoxynucleotides containing 7-propynyl-, 7-iodo- and 7-cyano-7-deaza-2-amino-2'-deoxyadenosines.

Balow G, Mohan V, Lesnik EA, Johnston JF, Monia BP, Acevedo OL.

Nucleic Acids Res. 1998 Jul 15;26(14):3350-7.

15.
16.

Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo.

Monia BP, Sasmor H, Johnston JF, Freier SM, Lesnik EA, Muller M, Geiger T, Altmann KH, Moser H, Fabbro D.

Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15481-4.

17.

Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathway.

Schulte TW, Blagosklonny MV, Romanova L, Mushinski JF, Monia BP, Johnston JF, Nguyen P, Trepel J, Neckers LM.

Mol Cell Biol. 1996 Oct;16(10):5839-45.

18.

Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras.

Monia BP, Johnston JF, Sasmor H, Cummins LL.

J Biol Chem. 1996 Jun 14;271(24):14533-40.

19.

Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase.

Monia BP, Johnston JF, Geiger T, Muller M, Fabbro D.

Nat Med. 1996 Jun;2(6):668-75. Erratum in: Nat Med. 1999 Feb;5(2):127.

PMID:
8640558
20.

Clinical use of the Relaxograph NMT-100.

Lekowski RW, Johnston JF.

Anesthesiol Rev. 1994 Jan-Feb;21(1):22-6. No abstract available.

PMID:
10172018
21.

Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides.

Monia BP, Johnston JF, Ecker DJ, Zounes MA, Lima WF, Freier SM.

J Biol Chem. 1992 Oct 5;267(28):19954-62.

22.

Percutaneous pulmonary artery catheterization in pediatric cardiovascular anesthesia: insertion techniques and use.

Introna RP, Martin DC, Pruett JK, Philpot TE, Johnston JF.

Anesth Analg. 1990 May;70(5):562-6. No abstract available.

PMID:
2331072
23.
24.

Room-temperature vs. ice-temperature injectate for thermodilution cardiac output determination.

Johnston JF.

Heart Lung. 1983 Sep;12(5):564. No abstract available.

PMID:
6554270
25.

Nursing management for barbiturate therapy in acute head injuries.

Johnston JF, McGraw CP.

Heart Lung. 1983 Jul;12(4):461-2. No abstract available.

PMID:
6553046
26.

Retrospectively..."writer's cramp.

Johnston JF.

J Indianap Dist Dent Soc. 1970 Nov;25(2):24-6. No abstract available.

PMID:
5275248
27.

Retrospectively.

Johnston JF.

J Indianap Dist Dent Soc. 1970 Mar;24(6):12-3. No abstract available.

PMID:
5266273
28.

Retrospectively...

Johnston JF.

J Indianap Dist Dent Soc. 1969 Dec;24(3):18-9. No abstract available.

PMID:
5261603
29.

Retrospectively...

Johnston JF.

J Indianap Dist Dent Soc. 1969 May;23(8):19-20. No abstract available.

PMID:
5254782
30.

Retrospectively . . .

Johnston JF.

J Indianap Dist Dent Soc. 1969 Jan;23(4):16-7. No abstract available.

PMID:
5250801
31.

Retrospectively.

Johnston JF.

J Indianap Dist Dent Soc. 1968 Dec;23(3):16-7. No abstract available.

PMID:
5247566
32.

Periodontal tissue changes in response to high artificial crowns.

Kemper WW, Johnston JF, HVan Huysen G.

J Prosthet Dent. 1968 Aug;20(2):160-4. No abstract available.

PMID:
5243745
33.

The dentist and the ceramic technician.

Johnston JF, Dykema RW.

J Tenn State Dent Assoc. 1968 Apr;48(2):83-91. No abstract available.

PMID:
5241077
34.

Tissue changes beneath fixed partial dentures.

Henry PJ, Johnston JF, Mitchell DF.

J Prosthet Dent. 1966 Sep-Oct;16(5):937-47. No abstract available.

PMID:
5222665
35.

Diagnosis and design for partial dentures.

Johnston JF, Maesaka RK.

Pract Dent Monogr. 1965 Sep-Oct:1-22. No abstract available.

PMID:
5173794
36.

Porcelain veneers bonded to metal castings.

JOHNSTON JF, MUMFORD G, DYKEMA RW.

Pract Dent Monogr. 1963 Mar;1963:1-32. No abstract available.

PMID:
14041970
37.

A micro-method for estimating inorganic phosphorus in serum or plasma.

JOHNSTON JF.

J Med Lab Technol. 1960 Jan;17:25-7. No abstract available.

PMID:
14407559
38.

Porcelain veneers fused to cast gold crowns.

JOHNSTON JF, DYKEMA RW, CUNNINGHAM DM.

J Am Dent Assoc. 1958 Jul;57(1):48-53. No abstract available.

PMID:
13549175
39.

ON THE USE OF NASAL SPRAYS AND DROPS.

Henderson VE, Beach ML, Johnston JF.

Can Med Assoc J. 1931 May;24(5):684-5. No abstract available.

40.

THE ADMINISTRATION OF GASTRIC ANTACIDS.

Johnston JF, Henderson VE.

Can Med Assoc J. 1931 Jan;24(1):77-9. No abstract available.

41.

THE FLAVOURING OF EXPECTORANT MIXTURES.

Johnston JF.

Can Med Assoc J. 1930 Sep;23(3):412-4. No abstract available.

42.

On the Composition and Physiological Action of the Water Recently Used in the Durham County Jail.

Johnston JFW.

Mon J Med (Edinb). 1855 May;20(5):377-380. No abstract available.

Supplemental Content

Loading ...
Support Center